MGX Minerals Announces Acquisition of Salinitas Lithium Brine Project at Salinas Grande Salar, Argentina

CSE:XMG, MGX Minerals, lithium,

MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to announce it has entered into an Option Agreement (the “Agreement”) with A.I.S. Resources (TSX.V:AIS) to acquire an 80% interest in the Salinitas lithium brine mining tenements (“Salinitas” or the “Project”) located in the lithium triangle of Argentina, Salar de Salinas Grandes, Province of Salta. The 4,308-hectare contiguous land package resides in the Puna region of northwest Argentina near the border of Chile, an area renowned for its lithium and potassium rich brine resources. read more

FSD Pharma Quebec Partner Cannara Biotech Closes Over $17.6 Million Equity Financing to Begin Build Out of First Phase of 625,000 Square Foot Indoor Grow

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTC:FSDDF) is pleased to announce its strategic partner Cannara Biotech Inc. (“Cannara”) closed $17.66 million common share equity financing. read more

FSD Pharma Appoints a Special Committee of the Board for Mergers and Acquisitions and Interim Chief Financial Officer

C.HUGE, FSD Pharma, cannabis, pot
Cision

Thomas Fairfull, President and Chief Executive Officer of FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTC:FSDDF), is pleased to announce the appointment of a Special Committee of the Board of Directors to focus on Merger and Acquisition Opportunities and also the appointment of Donal Carroll as interim Chief Financial Officer. read more

Triumph Gold Issues Options

V.TIG, Triumph gold, gold

Triumph Gold Corp. (TSX-V:TIG) (“Triumph” or the “Company”) is pleased to announce that pursuant to its stock option plan, the Company is issuing 800,000 options to officers and directors.  The options are priced at $0.40 and are valid for a period of 5 years. The stock options will vest 25% immediately, 25% after six months, 25% after twelve months and 25% after eighteen months. read more

FSD Pharma Surpasses One Billion Shares Traded and Makes History With Annual CSE Volume Trading Record in Less Than Two Months

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF), is pleased to report that it has traded over one Billion Class B subordinate voting shares and has broken the one year consecutive days of trading record on the Canadian Securities Exchange (“CSE”) in less than two months of trading. During the period of May 29, 2018 to July 18, 2018, the Company traded exactly 1,028,297,481 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”). Comparatively, the largest amount traded prior on the CSE in a one year period of consecutive days was 989,295,522. This is the largest total quantity of share volume ever traded by a CSE listed issuer within one year of consecutive days of trading as confirmed by the CSE. read more